(c) 2024 PillSync.com

teriflunomide 14 mg

1 INDICATIONS AND USAGE Teriflunomide is a pyrimidine synthesis inhibitor indicated for the treatment of relapsing forms of multiple sclerosis (MS), to include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease, in adults. ( 1 ) Teriflunomide is indicated for the treatment of relapsing forms of multiple sclerosis (MS), to include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease, in adults.

zydus pharmaceuticals usa inc.


8 months ago ROUND BLUE 1115 teriflunomide 14 mg

ROUND BLUE 1115

8 months ago ROUND BLUE 1115 teriflunomide 14 mg

1115 ROUND BLUE

16 HOW SUPPLIED/STORAGE AND HANDLING

TERIFLUNOMIDE Tablets, 7 mg and 14 mg are film-coated tablets.

TERIFLUNOMIDE Tablets, 7 mg are white to off white, round shaped, coated tablets debossed with "1114" on one side and plain on other side of tablet and are supplied as:. NDC 70710-1114-3 in bottle of 30 tablets with child-resistant closure NDC 70710-1114-8 in cartons of 28 tablets (2 x 14 tablets) (Unit-dose blisters are child-resistant)

TERIFLUNOMIDE Tablets, 14 mg are blue to light blue, round shaped, coated tablets debossed with "1115" on one side and plain on other side of tablet and are supplied as:. NDC 70710-1115-3 in bottle of 30 tablets with child-resistant closure NDC 70710-1115-8 in cartons of 28 tablets (2 x 14 tablets) (Unit-dose blisters are child-resistant) Store at 68°F to 77°F (20°C to 25°C) with excursions permitted between 59°F and 86°F (15°C and 30°C).


More pills like ROUND 1115












DISCLAIMER:

"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."

"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."

"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."

PillSync may earn a commission via links on our site